CAR+ T-Zell Therapie als mögliche neue Therapieoption für Cisplatin-resistente Plattenepithelkarzinome
Laryngo-rhino-otologiePeer ReviewedZ Poschinski +52021Conference proceedings
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support